Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Amortization - Intangibles (2024 - 2025)

Fortress Biotech has reported Amortization - Intangibles over the past 2 years, most recently at $1.1 million for Q4 2025.

  • Quarterly results put Amortization - Intangibles at $1.1 million for Q4 2025, up 12.84% from a year ago — trailing twelve months through Dec 2025 was $4.3 million (up 25.62% YoY), and the annual figure for FY2025 was $4.3 million, up 25.58%.
  • Amortization - Intangibles for Q4 2025 was $1.1 million at Fortress Biotech, up from $1.1 million in the prior quarter.
  • Over the last five years, Amortization - Intangibles for FBIO hit a ceiling of $1.1 million in Q4 2025 and a floor of $814000.0 in Q1 2024.